ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 22, 2025-

ConcertAI, Bayer join forces to advance precision oncology

Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI's Translational360 and AI SaaS offerings. The offerings use AI- and machine learning-acquired insights to speed up clinical development in precision oncology. The agreement aims to utilize ConcertAI's Translational360 offering, an integrated research-level longitudinal clinical molecular database that harnesse…

ConcertAI and Bayer to boost precision oncology with AI insights

ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.